Muscle Cell News Volume 9.21 | Jun 17 2024

    0
    46







    2024-06-17 | MUSCN 9.21


    Muscle Cell News by STEMCELL Technologies
    Vol. 9.21 – 17 June, 2024
    TOP STORY

    TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure

    Male and female control or tripartite motif containing 35 (TRIM35) overexpression adolescent and adult transgenic mice were used for all in vivo experiments.
    [Circulation]

    AbstractGraphical Abstract
    Wallchart: Reporting practices for publishing results with hPSCs. Request a copy.
    PUBLICATIONSRanked by the impact factor of the journal

    Fueling the Heartbeat: Dynamic Regulation of Intracellular ATP during Excitation–Contraction Coupling in Ventricular Myocytes

    Scientists conducted real-time measurements of intracellular adenosine triphosphate concentration ([ATP]i) in ventricular myocytes using a genetically encoded ATP fluorescent reporter. Their data revealed rapid beat-to-beat variations in [ATP]i.
    [Proceedings of The National Academy of Sciences of The United States of America]

    Full Article

    Endothelial Cell Signature in Muscle Stem Cells Validated by VEGFA-FLT1-AKT1 Axis Promoting Survival of Muscle Stem Cell

    Researchers used several computational analyses including single-cell RNAseq to show that muscle stem cells expressed low levels of canonical endothelial cell markers in mice.
    [eLife]

    Abstract

    Targeted Expression of Heme Oxygenase-1 in Satellite Cells Improves Skeletal Muscle Pathology in Dystrophic Mice

    Investigators generated a double-transgenic mouse model that allowed tamoxifen-inducible heme oxygenase-1 expression in Pax7 positive cells of dystrophic muscles.
    [Skeletal Muscle]

    Full Article

    PAI-1 Regulates the Cytoskeleton and Intrinsic Stiffness of Vascular Smooth Muscle Cells

    PAI-039, a specific inhibitor of plasminogen activator inhibitor-1 (PAI-1), and small interfering RNA were used to inhibit PAI-1 expression in cultured human smooth muscle cells.
    [Arteriosclerosis Thrombosis and Vascular Biology]

    Abstract

    Suppression of Smooth Muscle Cell Inflammation by Myocardin-Related Transcription Factors Involves Inactivation of TANK-Binding Kinase 1

    Researchers tested if myocardin-related transcription factors suppressed inflammation also by targeting cGAS-STING signaling. Interrogation of a transcriptomic dataset where myocardin was overexpressed using a panel of 56 cGAS-STING cytokines showed the panel to be repressed.
    [Scientific Reports]

    Full Article

    Corilagin Relieves Atherosclerosis via the Toll-Like Receptor 4 Signaling Pathway in Vascular Smooth Muscle Cells

    The cytotoxicity of corilagin was assessed using the CCK8 assay. Mouse vascular smooth muscle cells, pre-incubated with oxidized low-density lipoprotein, underwent treatment with varying concentrations of corilagin.
    [International Journal of Immunopathology and Pharmacology]

    Full Article
    Free E-Book: Genome Editing Applications for Disease Modeling and Cell Therapy.
    REVIEWS

    Circular RNA Regulatory Role in Pathological Cardiac Remodeling

    The authors summarize the current knowledge about circRNA origin, conservation, characteristics and function and discuss bioinformatics and wet-lab methods used in circRNA research.
    [British Journal of Pharmacology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Cranbury Pharmaceuticals Receives US FDA Approval for First Generic Version of Emflaza® Oral Suspension (Deflazacort) for Duchenne Muscular Dystrophy

    Cranbury Pharmaceuticals announced the US FDA approved the Abbreviated New Drug Application for the first generic version of Emflaza® oral suspension (deflazacort) for the treatment of Duchenne muscular dystrophy. The generic deflazacort oral suspension is now available to patients in the United States.
    [Tris Pharma]

    Press Release
    FEATURED EVENT

    International Retinoids Conference VII

    July 7 – 11, 2024
    Saint Paul, Minnesota, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Technician – Anatomy and Cell Biology

    Indiana University – Indianapolis, Indiana, United States

    Professor – Science Research

    KU Leuven – Leuven, Belgium

    Postdoctoral Researcher – Genome Editing for Inherited Muscular Disorders

    INSERM – Evry, France

    Group Leader – Structural Biology

    European Molecular Biology Laboratory (EMBL) – Grenoble, France

    Postdoctoral Associate – Bioengineered Models of Vascular Cells

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    > See All Jobs

    Submit (1)
    Brought to you by
    stemcell-logo-for newsletter-2